These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 10521296)

  • 1. The origins of hypertrophic cardiomyopathy-causing mutations in two South African subpopulations: a unique profile of both independent and founder events.
    Moolman-Smook JC; De Lange WJ; Bruwer EC; Brink PA; Corfield VA
    Am J Hum Genet; 1999 Nov; 65(5):1308-20. PubMed ID: 10521296
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and prognostic evaluation of familial hypertrophic cardiomyopathy in two South African families with different cardiac beta myosin heavy chain gene mutations.
    Posen BM; Moolman JC; Corfield VA; Brink PA
    Br Heart J; 1995 Jul; 74(1):40-6. PubMed ID: 7662452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A molecular screening strategy based on beta-myosin heavy chain, cardiac myosin binding protein C and troponin T genes in Italian patients with hypertrophic cardiomyopathy.
    Girolami F; Olivotto I; Passerini I; Zachara E; Nistri S; Re F; Fantini S; Baldini K; Torricelli F; Cecchi F
    J Cardiovasc Med (Hagerstown); 2006 Aug; 7(8):601-7. PubMed ID: 16858239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of mutations in symptomatic patients with hypertrophic cardiomyopathy in Taiwan.
    Chiou KR; Chu CT; Charng MJ
    J Cardiol; 2015 Mar; 65(3):250-6. PubMed ID: 25086479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and Prognostic Profiles of Cardiomyopathies Caused by Mutations in the Troponin T Gene.
    Ripoll-Vera T; Gámez JM; Govea N; Gómez Y; Núñez J; Socías L; Escandell Á; Rosell J
    Rev Esp Cardiol (Engl Ed); 2016 Feb; 69(2):149-58. PubMed ID: 26507537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A founder MYBPC3 mutation results in HCM with a high risk of sudden death after the fourth decade of life.
    Calore C; De Bortoli M; Romualdi C; Lorenzon A; Angelini A; Basso C; Thiene G; Iliceto S; Rampazzo A; Melacini P
    J Med Genet; 2015 May; 52(5):338-47. PubMed ID: 25740977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic predictive value of gene mutations in Japanese patients with hypertrophic cardiomyopathy.
    Chida A; Inai K; Sato H; Shimada E; Nishizawa T; Shimada M; Furutani M; Furutani Y; Kawamura Y; Sugimoto M; Ishihara J; Fujiwara M; Soga T; Kawana M; Fuji S; Tateno S; Kuraishi K; Kogaki S; Nishimura M; Ayusawa M; Ichida F; Yamazawa H; Matsuoka R; Nonoyama S; Nakanishi T
    Heart Vessels; 2017 Jun; 32(6):700-707. PubMed ID: 27885498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical features, spectrum of causal genetic mutations and outcome of hypertrophic cardiomyopathy in South Africans.
    Ntusi NA; Shaboodien G; Badri M; Gumedze F; Mayosi BM
    Cardiovasc J Afr; 2016; 27(3):152-158. PubMed ID: 27841901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of HCM causing mutations: lessons learnt from genotype-phenotype studies of the South African founder MYH7 A797T mutation.
    Moolman-Smook J; De Lange W; Corfield V; Brink P
    J Med Genet; 2000 Dec; 37(12):951-6. PubMed ID: 11186938
    [No Abstract]   [Full Text] [Related]  

  • 10. Identification of the genotypes causing hypertrophic cardiomyopathy in northern Sweden.
    Mörner S; Richard P; Kazzam E; Hellman U; Hainque B; Schwartz K; Waldenström A
    J Mol Cell Cardiol; 2003 Jul; 35(7):841-9. PubMed ID: 12818575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene mutations in apical hypertrophic cardiomyopathy.
    Arad M; Penas-Lado M; Monserrat L; Maron BJ; Sherrid M; Ho CY; Barr S; Karim A; Olson TM; Kamisago M; Seidman JG; Seidman CE
    Circulation; 2005 Nov; 112(18):2805-11. PubMed ID: 16267253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Properties of mutant contractile proteins that cause hypertrophic cardiomyopathy.
    Redwood CS; Moolman-Smook JC; Watkins H
    Cardiovasc Res; 1999 Oct; 44(1):20-36. PubMed ID: 10615387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetics of hypertrophic cardiomyopathy in eastern Finland: few founder mutations with benign or intermediary phenotypes.
    Jääskeläinen P; Miettinen R; Kärkkäinen P; Toivonen L; Laakso M; Kuusisto J
    Ann Med; 2004; 36(1):23-32. PubMed ID: 15000344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutations in the cardiac myosin-binding protein C gene are the predominant cause of familial hypertrophic cardiomyopathy in eastern Finland.
    Jääskeläinen P; Kuusisto J; Miettinen R; Kärkkäinen P; Kärkkäinen S; Heikkinen S; Peltola P; Pihlajamäki J; Vauhkonen I; Laakso M
    J Mol Med (Berl); 2002 Jul; 80(7):412-22. PubMed ID: 12110947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic diagnosis of hypertrophic cardiomyopathy using mass spectrometry DNA arrays and high resolution melting.
    Santos S; Lança V; Oliveira H; Branco P; Silveira L; Marques V; Brito D; Madeira H; Bicho M; Fernandes AR
    Rev Port Cardiol; 2011 Jan; 30(1):7-18. PubMed ID: 21425739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical outcomes associated with sarcomere mutations in hypertrophic cardiomyopathy: a meta-analysis on 7675 individuals.
    Sedaghat-Hamedani F; Kayvanpour E; Tugrul OF; Lai A; Amr A; Haas J; Proctor T; Ehlermann P; Jensen K; Katus HA; Meder B
    Clin Res Cardiol; 2018 Jan; 107(1):30-41. PubMed ID: 28840316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonfamilial Hypertrophic Cardiomyopathy: Prevalence, Natural History, and Clinical Implications.
    Ingles J; Burns C; Bagnall RD; Lam L; Yeates L; Sarina T; Puranik R; Briffa T; Atherton JJ; Driscoll T; Semsarian C
    Circ Cardiovasc Genet; 2017 Apr; 10(2):. PubMed ID: 28408708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Presence of Hypertrophic Cardiomyopathy Related Gene Mutations and Clinical Manifestations in Vietnamese Patients With Hypertrophic Cardiomyopathy.
    Tran Vu MT; Nguyen TV; Huynh NV; Nguyen Thai HT; Pham Nguyen V; Ho Huynh TD
    Circ J; 2019 Aug; 83(9):1908-1916. PubMed ID: 31308319
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiac troponin T Arg92Trp mutation and progression from hypertrophic to dilated cardiomyopathy.
    Fujino N; Shimizu M; Ino H; Okeie K; Yamaguchi M; Yasuda T; Kokado H; Mabuchi H
    Clin Cardiol; 2001 May; 24(5):397-402. PubMed ID: 11346248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of left ventricular hypertrophy in adults in hypertrophic cardiomyopathy caused by cardiac myosin-binding protein C gene mutations.
    Maron BJ; Niimura H; Casey SA; Soper MK; Wright GB; Seidman JG; Seidman CE
    J Am Coll Cardiol; 2001 Aug; 38(2):315-21. PubMed ID: 11499718
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.